CG Oncology (NASDAQ: CGON) director receives 9,354 stock options at $56.09 exercise price
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
CG Oncology, Inc. director Victor Edward Tong Jr. received a grant of stock options covering 9,354 shares of common stock. The options have an exercise price of $56.09 per share and expire on June 3, 2036.
These options vest in 12 equal monthly installments after June 4, 2026, the grant date. If the next annual stockholder meeting occurs before the first anniversary of the grant, any remaining unvested portion vests on the meeting date, contingent on his continued service.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Tong Victor Edward Jr
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Director Stock Option (right to buy) | 9,354 | $0.00 | -- |
Holdings After Transaction:
Director Stock Option (right to buy) — 9,354 shares (Direct, null)
Footnotes (1)
- [object Object]
Key Figures
Stock options granted: 9,354 options
Exercise price: $56.09 per share
Expiration date: June 3, 2036
+2 more
5 metrics
Stock options granted
9,354 options
Director stock option grant covering common stock
Exercise price
$56.09 per share
Strike price for the 9,354-share option grant
Expiration date
June 3, 2036
Option term end date for director grant
Post-grant derivative holdings
9,354 options
Total derivative securities following transaction
Vesting start date
June 4, 2026
Monthly vesting of 1/12 of options begins after this date
Key Terms
Director Stock Option, exercise price, expiration date, vesting, +1 more
5 terms
Director Stock Option financial
"Director Stock Option (right to buy)"
exercise price financial
"conversion_or_exercise_price": "56.0900""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
expiration date financial
"expiration_date": "2036-06-03T00:00:00.000Z""
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
vesting financial
"1/12th of the total number of shares of common stock subject to the option vest monthly"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
Grant, award, or other acquisition financial
"transaction_code_description": "Grant, award, or other acquisition""
FAQ
What did CGON director Victor Edward Tong Jr. report in this Form 4?
He reported receiving a grant of stock options for 9,354 shares of CG Oncology common stock. The options are compensation-related, not an open-market purchase, and give him the right to buy shares at a fixed exercise price in the future.
What is the exercise price of the CGON stock options granted to the director?
The options have an exercise price of $56.09 per share. This means he can buy up to 9,354 CG Oncology common shares at $56.09, regardless of the market price when he chooses to exercise, once the options have vested.
How do the CGON director stock options vest for this Form 4 grant?
The options vest in 12 equal monthly installments after June 4, 2026. If CG Oncology’s next annual stockholder meeting occurs before the first anniversary of the grant, any remaining unvested options fully vest on that meeting date, subject to continued service.
When do the CG Oncology (CGON) director stock options expire?
The options expire on June 3, 2036. After this expiration date, any unexercised portion of the 9,354-share option grant can no longer be exercised, so the director must exercise vested options before that date to acquire the underlying shares.